Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001041302 | SCV001204907 | pathogenic | not provided | 2024-05-02 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg1202*) in the PCARE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCARE are known to be pathogenic (PMID: 20398886, 24339724, 26496393). This variant is present in population databases (rs748396645, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with PCARE-related retinal dystrophy (PMID: 28763557). ClinVar contains an entry for this variant (Variation ID: 839525). For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001074821 | SCV001240420 | pathogenic | Retinal dystrophy | 2019-07-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001041302 | SCV001765342 | pathogenic | not provided | 2019-11-14 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Identified in an individual with retinitis pigmentosa who had an additional C2orf71 variant in published literature; segregation data was not included (Gerth-Kahlert et al., 2017); This variant is associated with the following publications: (PMID: 28763557) |
Genomics England Pilot Project, |
RCV001542737 | SCV001760083 | likely pathogenic | Retinitis pigmentosa 54 | no assertion criteria provided | clinical testing |